Statistical Programming Intern
Genmab is an international biotechnology company focused on improving patients' lives through innovative antibody therapeutics. The Statistical Programming Internship offers students hands-on experience in drug development, involving clinical research programming and collaboration across functions to support data analysis and visualization. Responsibilities Gain hands-on experience with programming tools including SAS, R, and Python Support the production of analysis datasets, tables, figures, and listings by writing, testing, and validating corresponding programs Develop data visualizations or tools to streamline and automate programming tasks Learn industry standards, best practices, and regulatory requirements for Clinical and Statistical Programming Support reporting and visualization of clinical trial data Gain familiarity with computing environments, applications, and tools used in Clinical and Statistical Programming Participate in weekly mentorship meetings with programming and team leads Engage in networking and cross-functional collaboration with teams such as Biostatistics and Data Management Complete a project based on a real Programming assignment (e.g., automation of data package checks for FDA submissions or testing standard code libraries) Present the completed project to the Extended Programming Leadership Team and other stakeholders, demonstrating skills, insights, and potential for future full-time opportunities Skills Students in their second year of a Master's degree in Statistics, Mathematics, Computer Science, Bioinformatics, Data Science or related fields. (Expected Graduation: December 2026 or May 2027) Interest in clinical research Basic understanding of Clinical and/or Statistical Programming Academic experience with relevant programming languages (e.g. SAS, R, Python) Advanced experience with relevant programming languages (e.g. SAS, R, Python) Company Overview Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. It was founded in 1999, and is headquartered in Copenhagen, Hovedstaden, DNK, with a workforce of 1001-5000 employees. Its website is